Aug 12, 2026 06:56AM
Aug 10, 2026 08:00AM
May 5, 2026 08:00AM
Feb 17, 2026 08:00AM
Nov 3, 2025 09:01AM
Sep 16, 2025 12:42PM
Sep 16, 2025 06:44AM Raymond James Adjust Analyst Current Favorites List
Aug 5, 2025 08:00AM
May 6, 2025 08:00AM
Feb 25, 2025 08:00AM
Nov 13, 2024 07:11AM
Nov 12, 2024 08:02AM
Nov 12, 2024 08:00AM
Aug 6, 2024 09:48AM Cogint (COGT) Misses Q2 EPS by 3c
Aug 6, 2024 08:00AM
May 7, 2024 08:06AM
May 7, 2024 08:00AM
Feb 26, 2024 09:24AM
Feb 26, 2024 08:00AM
Nov 2, 2023 09:00AM
Aug 8, 2023 08:00AM Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial Results
Jun 6, 2023 05:24PM
May 9, 2023 08:00AM
Mar 14, 2023 08:00AM
Nov 14, 2022 07:00AM
Aug 9, 2022 07:00AM
May 10, 2022 07:00AM
Mar 15, 2022 07:00AM Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
Nov 10, 2021 07:00AM
Aug 16, 2021 12:33PM
Aug 16, 2021 07:00AM
May 12, 2021 01:49PM
May 12, 2021 07:00AM
Mar 16, 2021 07:00AM
Nov 9, 2020 07:00AM Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Mar 14, 2018 04:08PM
Mar 14, 2018 04:05PM
Mar 2, 2018 08:45AM
Jan 4, 2018 09:28AM
Nov 8, 2017 04:33PM
Nov 8, 2017 04:05PM
Oct 31, 2017 06:55AM cogint to Announce Third Quarter 2017 Financial Results on November 8, 2017
Aug 9, 2017 04:15PM
Aug 9, 2017 04:05PM
Aug 3, 2017 06:55AM
May 9, 2017 04:16PM
May 9, 2017 04:05PM
May 1, 2017 06:55AM
Mar 13, 2017 08:29AM Chardan Capital Markets Reiterates Buy on Cogent (COGT) Following 4Q
Mar 9, 2017 04:13PM

1,222,606 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All